New curcumin ingredient for RTD beverages at Vitafoods Europe
The new ingredient, Curcugen, is said to be a 100% natural, water-dispersible curcumin ingredient.
Photo © Shutterstock.com/COLOA Studio
DolCas-Tenshi Bioceuticals Inc., a new joint venture between DolCas Biotech LLC (Landing, NJ) and Tenshi Kaizen Private Ltd. (Bengaluru, India), will introduce a new, bioavailable curcumin ingredient for ready-to-drink (RTD) beverages at the upcoming Vitafoods Europe trade show taking place May 7-9 in Geneva, Switzerland.
According to the companies, the new ingredient, Curcugen, is a 100% natural, water-dispersible curcumin ingredient. “Curcugen’s patent-pending composition base is a novel-source turmeric oleoresin, rather than the 95% standardized curcuminoid material common in the supplement industry,” the companies' press release states. “The Self D platform technology”-created by a company called Olene Life Sciences Pvt. Ltd.-“optimizes the oleoresin base so that its benefits can be fully realized.” In short, the companies say, the oleoresin matrix preserves and optimizes the ingredient’s complex of curcuminoids, essential oils, and polar resins-all of which, they say, help to overcome any absorption issues typical with unformulated curcumin ingredients. The technology also helps promotes the ingredient’s dispersibility in beverages.
“Curcugen was developed using our patented SELF D platform technology,” said Somashekara Nirvanashetty, PhD, CEO and cofounder of Olene Life Sciences Pvt. Ltd., in the DolCas-Tenshi Bioceuticals press release. “It is a truly ‘disruptive innovation’ sure to redefine the curcumin landscape, allowing Curcugen to emerge as one of the leading curcumin products globally.”
DolCas-Tenshi Bioceuticals claims that Curcugen is “among the most concentrated curcumin ingredients on the market.”
Visit Vitafoods booth #F200
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
